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Abstract
Objective:  This  study  aimed  to  critically  review  the  literature  available  regarding  the  Zika  virus
outbreak  in  Brazil  and  its  possible  association  with  microcephaly  cases.
Sources:  Experts  from  Instituto  do  Cérebro  do  Rio  Grande  do  Sul  performed  a  critical  (nonsys-
tematic) literature  review  regarding  different  aspects  of  the  Zika  virus  outbreak  in  Brazil,  such
as transmission,  epidemiology,  diagnostic  criteria,  and  its  possible  association  with  the  increasedevelopment;
Neuroimaging of microcephaly  reports.  The  PubMed  search  using  the  key  word  ‘‘Zika  virus’’  in  February  2016
yielded 151  articles.  The  manuscripts  were  reviewed,  as  well  as  all  publications/guidelines  from
the Brazilian  Ministry  of  Health,  World  Health  Organization  and  Centers  for  Disease  Control  and
Prevention  (CDC  --  United  States).
 Please cite this article as: Nunes ML, Carlini CR, Marinowic D, Neto FK, Fiori HH, Scotta MC, et al. Microcephaly and Zika virus: a clinical
nd epidemiological analysis of the current outbreak in Brazil. J Pediatr (Rio J). 2016;92:230--40.
 Study carried out at Instituto do Cérebro (InsCer) do Rio Grande do Sul and Faculdade de Medicina, Pontifícia Universidade Católica do
io Grande do Sul (PUCRS), Porto Alegre, RS, Brazil.
∗ Corresponding author.
E-mail: nunes@pucrs.br (M.L. Nunes).
ttp://dx.doi.org/10.1016/j.jped.2016.02.009
021-7557/© 2016 Sociedade Brasileira de Pediatria. Published by Elsevier Editora Ltda. This is an open access article under the CC BY-NC-ND
icense (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Summary  of  ﬁndings:  Epidemiological  data  suggest  a  temporal  association  between  the
increased number  of  microcephaly  notiﬁcations  in  Brazil  and  outbreak  of  Zika  virus,  primarily
in the  Brazil’s  Northeast.  It  has  been  previously  documented  that  many  different  viruses  might
cause congenital  acquired  microcephaly.  Still  there  is  no  consensus  on  the  best  curve  to  mea-
sure cephalic  circumference,  speciﬁcally  in  preterm  neonates.  Conﬂicting  opinions  regarding
the diagnosis  of  microcephaly  (below  2  or  3  standard  deviations)  that  should  be  used  for  the
notiﬁcations  were  also  found  in  the  literature.
Conclusion:  The  development  of  diagnostic  techniques  that  conﬁrm  a  cause--effect  association
and studies  regarding  the  physiopathology  of  the  central  nervous  system  impairment  should  be
prioritized.  It  is  also  necessary  to  strictly  deﬁne  the  criteria  for  the  diagnosis  of  microcephaly
to identify  cases  that  should  undergo  an  etiological  investigation.
© 2016  Sociedade  Brasileira  de  Pediatria.  Published  by  Elsevier  Editora  Ltda.  This  is  an  open
access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/
4.0/).
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Microcefalia  e  vírus  Zika:  um  olhar  clínico  e  epidemiológico  do  surto  em  vigência  no
Brasil
Resumo
Objetivos:  O  objetivo  deste  estudo  foi  realizar  uma  revisão  crítica  da  literatura  sobre  o  surto
de vírus  Zika  no  Brasil  e  sua  possível  associac¸ão  com  casos  de  microcefalia.
Fonte de  dados:  Especialistas  em  áreas  aﬁns  do  Instituto  do  Cérebro  do  Rio  Grande  do  Sul
realizaram uma  revisão  crítica  (não  sistemática)  da  literatura  sobre  o  vírus  Zika,  suas  formas  de
transmissão,  a  epidemia  no  Brasil,  critérios  diagnósticos  e  a  possível  associac¸ão  com  os  casos
crescentes de  microcefalia.  O  uso  da  palavra  chave  ‘‘Zika  virus’’  na  base  de  dados  do  PubMed
em fevereiro  de  2016,  retorna  151  publicac¸ões.  Estes  textos  foram  revisados  assim  como  todas
as publicac¸ões  e  recomendac¸ões  do  Ministério  da  Saúde,  Organizac¸ão  Mundial  da  Saúde  e  Centro
de Controle  de  Doenc¸as  (CDC  --  USA).
Síntese  dos  dados:  Os  dados  epidemiológicos  sugerem  uma  relac¸ão  temporal  entre  aumento
da notiﬁcac¸ão  de  casos  de  microcefalia  e  o  surto  de  vírus  Zika,  principalmente  no  Nordeste
do Brasil.  Agentes  virais  comprovadamente  podem  ser  causadores  de  microcefalia  congênita
adquirida.  Não  existe  um  consenso  sobre  a  melhor  curva  de  perímetro  cefálico  a  ser  utilizada,
principalmente  nos  prematuros.  Assim  como  também  existem  divergências  sobre  a  deﬁnic¸ão  de
microcefalia  (abaixo  de  2  ou  3  desvios  padrões)  a  ser  padronizada  nas  notiﬁcac¸ões.
Conclusão:  Deve-se  priorizar  o  desenvolvimento  de  técnicas  diagnósticas  que  conﬁrmem  uma
relac¸ão causa--efeito  e  estudos  sobre  mecanismos  da  patogênese  da  infecc¸ão  pelo  Zika  no  sis-
tema nervoso  central.  Também  é  necessário  deﬁnir  e  universalizar  os  critérios  diagnósticos  para
a identiﬁcac¸ão  dos  casos  de  microcefalia  que  devem  ser  submetidos  à  investigac¸ão  etiológica.
© 2016  Sociedade  Brasileira  de  Pediatria.  Publicado  por  Elsevier  Editora  Ltda.  Este e´  um  artigo
Open Access  sob  uma  licenc¸a  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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The  World  Health  Organization  (WHO)  has  issued  a  warning
establishing  an  international  state  of  emergency  due  to  the
microcephaly  incidence  increase  in  endemic  areas  with  Zika
virus  (ZikaV)  proliferation.1
The  disease,  which  arrived  in  Brazil  possibly  in  2014,  has
spread  in  the  Northeast  region  and  is  migrating  to  the  Amer-
icas.  It  is  believed  that  it  will  quickly  continue  spreading,
as  its  main  vector,  the  Aedes  aegypti  mosquito,  is  undergo-
ing  a  period  of  wide  dissemination  due  to  the  high  summer
temperatures  in  the  southern  hemisphere.2--4A  possible  association  between  intrauterine  infection  by
ZikaV  and  early  microcephaly  was  initially  proposed,  based
on  the  observation  of  physicians  in  Northeastern  Brazil,
who  detected  a  sudden  increase  in  the  incidence  of  births
o
p
ef  microcephalic  children  after  identiﬁcation  of  the  virus
ntry  in  Brazil.  However,  this  cause--effect  association  still
eeds  to  be  proven.5,6 The  fact  is  that  the  ZikaV  enters  the
entral  nervous  system  (CNS),  breaking  the  protection  of
he  blood--brain  barrier,  which  has  been  previously  demon-
trated  in  animal  experiments.7,8
The  recent  discovery  of  other  forms  of  virus  transmis-
ion,  in  addition  to  an  infected  insect  bite,  through  sexual
ontact  or  secretions  (saliva,  urine),  and  the  lack  of  vaccines
r  speciﬁc  treatment  has  alarmed  the  population.  Moreover,
he  lack  of  longer-duration  biological  markers  that  allow  for
iagnostic  conﬁrmation,  geometrically  increase  the  number
f  suspected  cases  and,  consequently,  the  recording  of  false
ositive  cases.9--11
Pediatricians  are  exposed  to  the  demand  for  knowl-
dge  of  this  new  disease,  as  they  treat  the  neonate  and
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nitiate  the  investigation  of  the  microcephaly  status.  As  the
cientiﬁc  literature  is  still  scarce  and  new  ﬁndings  and  infor-
ation  have  quickly  appeared  and  been  widely  disseminated
n  the  media,  this  article  aimed  to  bring  together  a multi-
isciplinary  group  of  experts  in  associated  ﬁelds  to  critically
eview  the  scientiﬁc  evidence,  diagnostic  protocols,  differ-
ntial  diagnosis,  and  research  perspectives  that  allow  for  the
onﬁrmation  of  the  association  between  ZikaV  and  micro-
ephaly.
ethods
his  was  a  non-systematic  review  article  conducted  by  a
anel  of  experts.  This  article  was  divided  into  topics  consid-
red  signiﬁcant  for  a  better  understanding  of  ZikaV  outbreak
n  Brazil,  such  as  the  diagnostic  difﬁculties  of  this  infec-
ion  and  the  differential  diagnosis  with  other  infections
hose  vector  is  also  the  Aedes  aegypti  mosquito;  biologi-
al  characteristics  of  ZikaV;  possible  associations  between
ikaV  infection  and  CNS  development  alterations;  criteria
or  determining  microcephaly;  and  etiological  differential
iagnosis  of  microcephalies.  Additionally,  the  article  dis-
usses  possible  experimental  models  that  would  help  to
nderstand  the  physiopathogenesis  of  CNS  lesions.
esults
he  use  of  the  key  word  ‘‘Zika  virus’’  in  the  PubMed
atabase  in  February  2016  yielded  151  publications.  These
exts  were  reviewed,  as  well  as  all  publications  and  rec-
mmendations  from  the  Brazilian  Ministry  of  Health,  World
ealth  Organization,  and  Centers  for  Disease  Control  and
revention  (CDC  --  United  States).
tages  of  intrauterine  development  of  the  central
ervous system  (CNS)  and  associated  disorders
he  CNS  development  in  humans  starts  at  the  gastrulation
tage,  approximately  on  the  14th  embryonic  day,  when  the
hickening  of  the  ectodermal  membrane  occurs,  originat-
ng  the  neural  plate.  Subsequently,  two  major  processes  will
ccur  sequentially:  the  formation  of  the  neural  tube  and  the
evelopment  of  the  prosencephalon.  Table  1  lists  the  devel-
pmental  milestones,  the  time  of  their  occurrence,  and  the
efects  arising  from  problems  occurring  at  these  stages.12
The  proliferation  phase  is  quite  complex  and  broad,  start-
ng  around  the  second  to  the  fourth  month  of  pregnancy,
ith  neuronal  proliferation  and  generation  of  glial  radial
ells,  extending  from  the  ﬁfth  month  until  the  end  of  the
rst  year  of  life,  when  glial  proliferation  occurs.  The  ini-
ial  process  is  characterized  by  the  germinal  matrix  stem
ells  that  divide  symmetrically,  forming  the  proliferative
euronal--glial  units,  which  are  distributed  in  the  periven-
ricular  zone.  After  that,  an  asymmetric  division  starts,  in
hich  each  stem  cell  originates  another  stem  cell  and  a  post-
itotic  neuronal  cell.  This  asymmetric  division  determineshe  proliferative  unit  size.13
The  postmitotic  neurons  migrate  along  the  radial  glia  to
orm  the  different  layers  of  the  cerebral  cortex.  Approx-
mately  one-third  of  the  neurons  do  not  use  the  radial
p
a
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lia  structure  and  migrate  tangentially  in  the  cortical
irection.14 During  the  migration  process,  neurons  pass
hrough  neurons  that  are  already  positioned  in  the  cortex,
eading  to  a  lamination  where  the  last  arriving  neurons  in
ortical  area  position  themselves  on  the  outermost  surface
f  the  cortex.  This  ﬁnal,  histologically  distinct  six-layer  orga-
ization  comprises  an  extraordinary  diversity  of  neuronal
ubtypes,  working  as  units  for  the  formation  of  a  power-
ul  neural  circuit.  In  recent  years,  remarkable  progress  has
een  made  to  understand  the  molecular  events  that  con-
rol  the  development  of  the  cerebral  cortex,  as  well  as  the
isorders  associated  with  alterations  in  this  process.15
The  alterations  in  the  cerebral  cortex  development  are
hown  as  a group  of  different  malformations  whose  patho-
enesis  is  not  well  deﬁned  yet.  Among  the  cortical  defects,
 subset  of  conditions  has  been  associated  with  alter-
tions  in  cell  migration  and  neurodifferentiation,  among
hem  the  lissencephalies,  polymicrogyria,  and  focal  corti-
al  dysplasias.  Some  researchers  suggest  that  in  addition  to
lterations  in  cell  migration  and  neurodifferentiation,  one
ust  consider  other  factors  in  the  pathogenesis  of  cortical
alformations,  such  as  cell  proliferation,  cell  death,  intra-
ortical  growth  and  development  after  cell  migration,  and
he  formation  of  axons  and  dendrites.16,17
The  majority  of  pathologies  associated  with  cell  migra-
ion  alterations  have  a  variety  of  genes  that  may  be
ssociated  with  the  diseased  phenotype,  but  in  some  cases
ts  appearance  is  sporadic.  The  high  epileptogenicity  of  the
ortex  in  these  cases  is  noteworthy.18
Several  environmental  factors  have  been  identiﬁed
s  causing  cortical  defects;  maternal  exposure  during
regnancy  to  agents  such  as  ethanol,  some  acids,  anticonvul-
ants,  mercury,  radiation,  and  viral  agents,  among  others,
ay  result  in  cortical  development  disorders  in  the  fetus.17
icrocephaly  diagnosis
he  observed  association  between  fetal  infection  by  ZikaV
nd  the  occurrence  of  microcephaly  at  birth  has  increased
he  importance  of  an  accurate  diagnosis  of  microcephaly.
t  is  necessary  to  identify  possible  cases  and  at  the  same
ime,  avoid  expensive  investigation  and  a  state  of  alertness
n  the  healthcare  system.  In  practice,  a  head  circumference
t  birth  smaller  than  two  standard  deviations  of  the  mean  for
estational  age  has  been  used  for  clinical  diagnosis  of  micro-
ephaly.  Reports  on  the  prevalence  of  microcephaly  using
his  criterion  were  approximately  0.5%,  which  is  well  below
hat  would  be  expected  for  two  standard  deviations.19,20
his  is  probably  due  to  a  non-normal  distribution  of  the
easured  head  circumference.  Severe  microcephaly,  i.e.,
maller  than  three  standard  deviations  of  the  mean,  occurs
n  1  per  1000  births.19
Although  it  is  a  relatively  simple  and  reliable  diagnos-
ic  method,  the  simple  head  circumference  measurement
ight  not  reﬂect  an  abnormally  small  brain  and  does  not
ffer  data  to  demonstrate  an  abnormal  skull  shape.  Thus,  it
s  extremely  important  that  the  measurement  and  its  inter-
retation  are  correct.
The  head  circumference  measurement  is  carried  out  with
 ﬂexible  and  inelastic  measuring  tape.  The  skull  diam-
ter  is  measured  at  its  largest  circumference,  using  the
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Table  1  Milestones  of  central  nervous  system  development.
Milestones  of
development
Description  Period  of  occurrence  Malformations  or  resulting
diseases
Primary
neurulation
Formation  of  the  neural  tube,
caudal  portion
3rd--4th  week  of  gestation Total  craniorachischisis
Anencephaly
Myeloschisis
Encephalocele
Myelomeningocele
Arnold--Chiari  malformation
Secondary
neurulation
Neural tube  formation,  sacral
portion  and  coccyx  of  the
spinal  column
4th--5th  week  of  gestation  Occult  dysraphic  states
(myelocystoceles,
diastematomyelia,
meningocele,  lipoma,
teratoma,  dermoid  cyst)
Prosencephalon
development
Neural tube  ventral  induction,
face  and  cerebral  hemispheres
formation
2nd--3rd  month  of  gestation  Aprosencephaly
Atelencephaly
Holoprosencephaly
Agenesis  of  the  corpus
callosum
Agenesis  of  septum  pellucidum
Septo-optic  dysplasia
Proliferation  Neuronal  proliferation,  of
radial  glial  cells  and  glia
3rd--4th  month  of  gestation  Microcephaly
Macrocephaly
Neuronal
migration
Dislocation  of  neuronal  cells
from  the  germinal  matrix  to
the  cerebral  cortex
3rd--5th  month  of  gestation  Lissencephaly
Schizencephaly
Pachygyria
Polymicrogyria
Neuronal  heterotopia
Focal  dysplasias
Organization  Neuron  differentiation
(alignment,  formation  of
cortical  layers),  synapse
development  (axonal  and
dendritic  branching),
apoptosis,  proliferation  and
differentiation  of  glia
5th  month  and  postnatal  Idiopathic  mental  retardation
Down  Syndrome
Fragile-X  syndrome
Angelman  syndrome
Autism
Potential  disorders  associated
with  prematurity  and
malnutrition
Peri  and  postnatal  injuries
Myelination  Acquisition  of  the  myelin
sheath  that  will  cover  the
axons
Birth  and  postnatal  White  matter  hypoplasia
Malnutrition
Prematurity
Organic  acidemia  and
aminoacidopathies
b
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aModiﬁed from Volpe.12
tape  around  the  head,  by  placing  it  on  the  forehead  above
the  eyes,  passing  it  above  the  ears  and  the  most  promi-
nent  portion  of  the  back  of  the  skull.  In  full-term  babies,
this  perimeter  must  be  greater  than  32  cm  (small  variation
by  gestational  age  and  gender).  The  head  circumference
increases  almost  linearly  up  to  37--38  weeks  of  gestation.21
The  choice  of  the  curve  and  the  criteria  used  to  deﬁne
microcephaly  has  been  the  subject  of  extensive  discussion,
especially  regarding  preterm  infants.22,23 The  Pan-American
Health  Organization  suggests  using  both  the  Fenton  curve
24--26and  the  curve  of  the  InterGrowth  study. However,  the
analysis  made  by  Victora  et  al.  shows  how  the  choice  of
the  curve  can  have  an  impact  on  the  number  of  suspected
cases,  exponentially  increasing  the  number  of  children  to
t
p
t
re  investigated  and  exposed  to  CT  radiation.  These  authors
uggest  that  tools  with  greater  speciﬁcity  should  be  given
riority,  such  as  the  InterGrowth  curve  in  exchange  for
ensitivity.23
It  is  also  important  to  perform  an  analysis  of  the  pro-
ortion  of  head  circumference  in  relation  to  other  growth
easures,  such  as  weight  and  length,  in  order  to  deﬁne  the
uspected  microcephaly  etiology.19
In  spite  of  being  an  objective  measure,  a  study  that
ssessed  interobserver  variation  showed  differences  of  more
27han  2  cm  in  5%  of  them. Therefore,  the  staff  that
erforms  the  measurement  should  be  trained  and,  when
he  measurement  is  borderline  or  abnormal,  it  should  be
epeated.
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In  the  presence  of  abnormal  skull  shapes  due  to  fam-
ly,  genetic  characteristics,  or  molding  caused  by  the  birth
rocess,  the  head  circumference  measurement  can  be  mis-
eading  and  not  reﬂect  a  reduction  in  brain  tissue.  One
uggestion  to  reduce  microcephaly  misdiagnosis  would  be
o  repeat  the  measurements  one  or  more  days  after  birth,
specially  in  the  presence  of  overriding  sutures  at  birth  with
orderline  measures.  The  abnormal  shape  should  lead  to  fur-
her  assessment  for  the  presence  of  craniosynostosis  and/or
enetic  diseases.
tiological  differential  diagnosis  of  microcephalies
he  more  adequate  term  is  microcephalies,  considering
he  different  forms,  etiologies,  and  clinical  expression.
he  pathogenesis  of  microcephaly  is  heterogeneous,  from
enetic  causes  to  environmental  factors  that  can  have  an
mpact  on  neurodevelopment  and,  thus,  inﬂuence  brain
rowth.  Therefore,  any  factor  that  can  interfere  with  cell
roliferation  and/or  differentiation,  cell  death,  among  oth-
rs,  can  induce  microcephaly.  These  factors  may  affect  the
rain  development  only  or  impair  other  parts  of  the  body,
etermining  dysmorphisms  (syndromic  microcephalies).22,28
To  facilitate  the  clinical  investigation  and  the  differential
iagnosis  of  microcephalies,  they  will  initially  be  classiﬁed
ased  on  the  time  of  diagnosis.  Thus,  microcephalies  can
e  divided  into  two  categories:  congenital  microcephaly,
hich  is  present  from  birth  and  postnatal  microcephaly,
hich  develops  after  the  neonatal  period  and,  in  general,
n  the  ﬁrst  two  years  of  life.22,28--30 The  microcephalies  may
e  genetic  or  acquired,  with  the  latter  encompassing  exter-
al/environmental  factors  that  are  potentially  harmful  to
he  brain.
In  acquired  congenital  microcephalies,  aggressive  fac-
ors  act  during  the  intrauterine  brain  development.
hese  factors  include  maternal  infections  (toxoplasmo-
is,  cytomegalovirus,  herpes  virus,  syphilis,  rubella,  human
mmunodeﬁciency  virus  [HIV],  and  now  the  possible
ssociation  with  ZikaV),  exposure  to  drugs/toxic  sub-
tances,  especially  the  maternal  consumption  of  alcohol
fetal  alcohol  syndrome),  radiation,  disruptive  factors
hat  disrupt  normal  brain  development  (e.g., hemorrhage,
schemia,  hypoxic--ischemic  syndrome,  and  traumatic  brain
njury),  and  nutritional  deﬁciency  (maternal  malnutri-
ion,  placental  failure,  hypothyroidism,  or  maternal  folate
eﬁciency).22,28,31--33
The  genetic  congenital  microcephalies  may  be  associated
ith  chromosomal  abnormalities  or  certain  genes,  such  as
he  autosomal  recessive  primary  microcephaly  (also  termed
icrocephaly  primary  hereditary  [MCPH],  and  historically
nown  as  microcephaly  vera),  in  which  at  least  12  genes
ave  been  identiﬁed  and  encode  proteins  associated  with
he  centrosome.34,35 Here  the  term  primary  microcephaly
orresponds  to  those  cases  in  which  the  reduction  in  brain
olume  is  primarily  due  to  the  reduction  of  the  neuronal
opulation  during  neurogenesis.29,36 In  general,  the  overall
tructure  of  the  brain  is  maintained  in  MCPH  and  there  are
o  other  malformations  or  alterations  in  brain  development
atterns.
Postnatal  microcephalies  are  those  in  which  the  child
s  born  with  normal  head  circumference,  with  a  reduction
o
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n  head  growth  velocity  over  time,  reaching  microcephaly
evels.  The  postnatal-onset  microcephalies  are  associated
ith  genetic  causes  or  external/environmental  (acquired)
actors.22
Examples  of  acquired  postnatal  microcephalies  include
hose  resulting  from  traumatic  brain  injury,  cerebral
schemia/hemorrhage,  encephalitis,  and  severe  malnutri-
ion,  among  others.  Several  postnatal  microcephalies  are
etermined  by  mutations  that  interfere  with  the  regulation
f  gene  expression  during  brain  development.30
Among  the  genetic  postnatal  microcephalies,  all  asso-
iated  with  mutations  (deletion,  insertion,  duplication,
usion,  and  amino  acid  point  mutations),  are  those  result-
ng  from  inborn  errors  of  metabolism,  neurodegenerative
iseases,  and  several  syndromes,  such  as  Angelman  syn-
rome,  Pitt--Hopkins  syndrome,  Rubinstein--Taybi  syndrome,
hristianson  syndrome,  and  MECP2-related  disorders  (Rett
yndrome).30
Knowledge  of  the  prevalence,  clinical  history,  and
etailed  clinical  and  neurological  assessment  can  lead  to  the
iagnosis.  The  clinical  history  may  reveal  exposure  to  agent,
ccident,  or  episode  harmful  to  the  brain,  and  the  clinical
ssessment  may  suggest  some  less  common  syndromes.
he  ZikaV
he  ZikaV,  which  belongs  to  the  Flaviviridae  family,  is
elated  to  other  ﬂaviviruses  of  medical  relevance  transmit-
ed  by  arthropod  vectors,  such  as  the  causative  agents  of
engue  fever,  Chikungunya  fever,  yellow  fever,  and  West
ile  encephalitis.  The  ZikaV  was  isolated  in  1947  from
on-human  primates  (sentinel  monkeys  for  yellow  fever
onitoring)  in  the  Zika  forest  in  Uganda,  which  was  adopted
s  the  name  for  this  virus.37
There  are  at  least  two  lineages  of  ZikaV,  the  African
ineage  (which  some  authors  divide  into  West  and  East
frica)  and  the  Asian  lineage.  Phylogenetic  studies  indicate
hat  the  virus  currently  spreading  in  the  Americas  derived
rom  the  Asian  lineage.38 ZikaV  transmission  occurs  primar-
ly  through  a  vector,  the  Aedes  mosquitoes;  in  the  sylvatic
ycle,  through  species  such  as  A.  albopictus,  among  others,
hereas  in  the  urban  cycle,  the  A.  aegypti  is  the  vector.
he  virus  is  transmitted  by  the  hematophagous  vector  during
eeding,  by  lodging  in  their  salivary  glands,  where  it  multi-
lies  without  affecting  the  insect,  remaining  in  it  throughout
ts  life.  In  addition  to  primates,  it  is  possible  that  other  mam-
als,  such  as  zebras,  elephants,  and  rodents,  can  also  be
atural  reservoirs  of  ZikaV.
Flaviviruses  are  small  (∼50  nm)  spherical  particles,  sur-
ounded  by  a  lipid  envelope.39 The  ZikaV  is  a  single-strand
NA  virus  with  10.794  kilobase,  with  two  non-coding  regions
nd  a  long  reading  frame  encoding  a  polyprotein.  That  is
leaved  by  host  cell  proteases  to  originate  the  capsid  protein
,  the  precursor  of  membrane  (prM)  and  envelope  E  protein,
nd  seven  non-structural  proteins,  called  NS1  to  NS7.  The
irions,  or  viral  particles,  contain  180  copies  of  protein  E,
nknown  amounts  of  other  proteins,  and  a  single  molecule
f  viral  RNA.  The  surface  of  the  virions  is  formed  by  E  and
 proteins.  The  E  protein  (∼53  kDa)  is  glycosylated,  being
he  main  viral  antigenic  determinant,  with  membrane  bind-
ng  and  fusion  functions  when  the  virus  enters  the  infected
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cell.40 It  has  been  postulated  that  virions  are  endocytosed
and  exposure  to  the  acidic  environment  in  lysosomes  pro-
motes  the  fusion  between  the  virus  envelope  and  the  cell
membranes.  Upon  release  of  viral  RNA  into  the  cytoplasm  of
infected  cells,  it  is  replicated  and  translated  by  the  cellular
machinery,  leading  to  the  formation  of  new  viral  particles.
Two  complete  genomes  of  the  ZikaV,  including  the  current
variety  circulating  in  the  Americas  are  now  available.38,41
Faye  et  al.  studied  37  virus  isolates  from  different
sources  (mosquitoes,  patients,  and  animals,  among  others.)
obtained  in  Africa,  showing  evidence  of  genetic  recombina-
tion  and  how  changes  in  the  glycosylation  pattern  of  protein
E  are  likely  adaptations  to  the  vector  A.  dalzielii.40 Freire
et  al.,  when  investigating  17  genomic  sequences  of  the  virus,
suggested  that  changes  in  the  use  of  codons  for  the  NS1  pro-
tein  in  the  Asian  lineage  of  the  ZikaV  can  be  correlated  with
higher  rates  of  replication  and  viral  titer  in  humans.42
Intrauterine  viral  infections  that  result  in  injuries  to  the
central  nervous  system  are  relatively  rare;  cytomegalovirus,
herpes  virus,  and  rubella  are  among  those  already  known  to
cause  fetal  diseases.  Among  Flaviviruses,  only  a  few  cases
of  West  Nile  encephalitis  virus  in  pregnant  women  were
reported  as  the  probable  cause  of  neurological  damage  in
fetuses.43
Epidemiology  and  surveillance  protocol  in  Brazil
The  ﬁrst  cases  of  human  infection  were  reported  in  Nigeria
and  Tanzania  from  1952  to  1954.37 The  virus  later  spread  to
the  Asian  continent  and  the  international  community  only
started  to  recognize  the  epidemic  potential  of  the  ZikaV
after  2005  and  especially  after  the  2007  outbreak  in  Microne-
sia  (Yap  island  in  the  Paciﬁc  Ocean)  and  the  2012/2013
outbreak  in  French  Polynesia.  Imported  cases  were  reported
after  2013  in  Germany,  Canada,  Italy,  Japan,  the  United
States,  and  Australia.  In  2014  the  presence  of  the  virus  was
described  in  the  Easter  Island  (Chile  --  Paciﬁc  Ocean).44 On
April  29,  2015,  the  circulation  of  this  virus  was  detected
for  the  ﬁrst  time  in  Brazil  and  Latin  America  (continent).
Researchers  from  the  Universidade  Federal  da  Bahia  (UFBA)
reported  the  identiﬁcation  of  ZikaV  by  RT-PCR  in  eight  of  the
25  tested  samples  (Camac¸ari/BA).3,45
In  October  2015,  the  Brazilian  government  initiated  joint
investigations  with  the  state  of  Pernambuco  after  observing
the  increasing  number  of  cases  of  microcephaly,  especially
in  that  state,  after  conﬁrmation  of  the  alteration  in  the
pattern  of  microcephaly  cases.  In  November,  it  launched
the  ﬁrst  National  Guideline  on  Microcephalies,  which  still
included  the  diagnosis  of  microcephaly  through  head  cir-
cumference  (HC)  measurement  ≤33  cm.  In  that  same  month,
after  conﬁrmation  of  the  presence  of  ZikaV  in  the  amniotic
ﬂuid  of  pregnant  women  in  the  state  of  Paraiba  by  Fiocruz,
the  association  of  ZikaV  infection  with  microcephaly  was
conﬁrmed.46 In  December,  the  government  released  the
Microcephaly  Protocol  --  Surveillance  --  Version  1,  chang-
ing  the  diagnosis  of  microcephaly,  which  started  to  be
considered  when  HC  was  ≤32  cm,  also  including  in  this  proto-
col  pregnant  women  with  rash,  miscarriage,  microcephalic
fetus,  and  stillbirth.44 On  December  14,  the  government
released  the  Microcephaly  Protocol  --  Health  Care.  It  is  worth
mentioning  that  this  change  in  head  circumference  measure
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or  the  diagnosis  of  microcephaly  can  inﬂuence  data  analy-
is.
In  January  2016,  the  National  Guideline  for  Early  Stimu-
ation  of  Babies  with  Microcephaly  was  released.  Four  cases
elated  to  ZikaV  were  also  identiﬁed  by  the  CDC  in  that
onth.  The  Brazilian  government  has  made  adjustments
n  the  operational  deﬁnitions  of  cases:  (A)  Deﬁnitions  of
ases  for  microcephaly  surveillance:  (i)  Newborn  with  micro-
ephaly,  (ii)  Miscarriage  suggestive  of  congenital  infection,
iii)  Stillbirth  with  microcephaly  and/or  CNS  malformations
uggestive  of  congenital  infection,  (iv)  Fetus  with  micro-
ephaly  and/or  CNS  alterations,  suggestive  of  congenital
nfection;  and  (B)  Deﬁnitions  of  cases  for  surveillance  of
ikaV  infection  during  pregnancy:  (i)  Pregnant  woman  with
cute  rash,  suggestive  of  ZikaV  infection.46
The  suspected  microcephaly  cases  must  be  reported
mmediately  to  the  health  authorities  and  registered  at  the
ublic  Health  Event  Registration  Form  (Registro  de  Even-
os  de  Saúde  Pública  [RESP]  --  Microcephalies),  available  at:
ww.resp.saude.gov.br. The  notiﬁcation  of  suspected  cases
f  microcephaly  in  the  RESP  does  not  exclude  the  need  to
eport  the  case  to  the  Live  Births  Information  System  (Sis-
ema  de  Informac¸ões  sobre  Nascidos  Vivos  [SINASC]).47,48
After  the  establishment  of  the  association  of  ZikaV  with
icrocephaly,  it  is  necessary  for  care  and  prevention  meas-
res  to  be  carried  out  and  intensiﬁed,  but  it  is  essential  to
xplain  and  sooth  the  population,  and  to  analyze  the  actual
umber  of  cases.
On  January  20,  2016,  the  Brazilian  Ministry  of  Health
ssued  an  epidemiological  report  with  some  relevant
nd  interesting  changes,  such  as  changing  the  name
‘Surveillance  and  Response  Protocol  to  the  Occurrence  of
icrocephaly  related  to  ZikaV  infection’’  to  ‘‘Surveillance
nd  Response  Protocol  to  the  Occurrence  of  Microcephaly,’’
egardless  of  the  cause.  This  same  report  describes,  in  sep-
rate,  the  224  cases  of  microcephaly  conﬁrmed  through
maging  assessment,  with  typical  alteration  in  the  six  cases
ith  positive  sample  for  ZikaV.49
Another  epidemiological  report  on  February  2,  2016
as  issued  with  a  cumulative  total  (2015--2016)  of  4783
eported  cases  of  microcephalies  and/or  other  CNS  disor-
ers,  including  possible  cases  related  to  ZikaV  and  other
nfections.  It  is  important  to  note  that  Brazil  does  not  have
lmost  5000  cases  of  ZikaV-related  microcephaly,  as  many
atients  and  also  some  health  professionals  may  imagine.
n  fact,  this  number  corresponds  to  the  notiﬁcation  of  sus-
ected  cases:  the  number  of  cases  still  under  investigation
s  3670,  whereas  the  number  of  cases  already  assessed  is
round  1113.  Of  these  assessed  cases,  microcephaly  related
o  congenital  infection  was  ruled  out  in  709  (63%).  The
emaining  cases,  404  (37%),  were  considered  conﬁrmed  for
icrocephaly  and/or  other  CNS  abnormalities,  although  the
dentiﬁcation  of  the  ZikaV  presence  in  the  amniotic  ﬂuid,
lacenta  and  fetal  tissues  occurred  in  only  17  cases  to
ate.49
Another  epidemiological  report  on  February  12,  2016  was
ssued  with  a  cumulative  total  (2015--2016)  of  5079  reported
ases  of  microcephaly  and/or  other  CNS  disorders,  including
ossible  cases  related  to  ZikaV  and  other  infections.  Since
he  beginning  of  the  investigations,  462  conﬁrmed  cases
ere  reported  in  175  municipalities  of  13  Brazilian  states.
he  northeast  region  has  98%  of  the  municipalities  with
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onﬁrmed  cases:  Pernambuco  has  167  cases,  followed  by
ahia  (101),  Rio  Grande  do  Norte  (70),  Paraíba  (54),  Piauí
29),  Alagoas  (21),  Ceará  (11)  Espírito  Santo  (3),  Rio  de
aneiro  (t2),  Pará  (1),  Goiás  (1),  Mato  Grosso  do  Sul  (1),
nd  Rio  Grande  do  Sul  (1).50
The  Brazilian  Medical  Genetics  Society-Zika  embryopa-
hy  Task  Force  indicates  four  case  report  limitations.  First,
 previous  underreporting  of  actual  cases  of  microcephalies
n  Brazil  and  the  fact  that  the  notiﬁcation  protocol  itself  may
ave  favored  the  increase  of  reported  cases.  Second,  mild
ases  of  microcephaly  might  not  have  been  notiﬁed  because
he  head  circumference  measurement  was  not  routinely  per-
ormed.  Third,  the  ZikaV  infection  was  not  conﬁrmed  in
ewborns  and  mothers  by  a  laboratory,  and  a  history  of
on-speciﬁc  rash  illness  during  pregnancy  is  subjective  and
an  lead  to  a  recall  bias,  resulting  in  misclassiﬁcation  of
otential  exposure  to  ZikaV.  Fourth:  the  reporting  of  cases
oes  not  comment  on  other  common  ﬁndings  in  intrauterine
nfections,  such  as  hepatosplenomegaly,  skin  rash,  choriore-
initis,  or  some  characteristics  that  have  been  reported  in
ases  of  suspected  ZikaV  infection,  including  hearing  loss,
ale  macula,  and  swallowing  difﬁculties.5
This  analysis  of  the  numbers  should  not  be  used  to
ecrease  preventive  measures;  however,  it  would  be  very
nteresting  to  advise  pregnant  women  to  adopt  measures  to
educe  the  presence  of  the  Aedes  aegypti,  by  eliminating
reeding  sites  and  protecting  themselves  against  mosquito
xposure,  by  keeping  doors  and  windows  closed  or  screened,
earing  long  pants  and  long-sleeved  shirts,  and  using  repel-
ents  allowed  during  pregnancy.
Multidisciplinary  advice,  such  as  the  routine  assessment
f  a  child  at  the  pediatrician,  can  be  an  opportunity  for  these
omen  to  receive  recommendations  on  planning  their  next
regnancy  and  that  they  should  consult  with  the  gynecolo-
ist  before  stopping  their  contraceptive  methods.
linical  picture  of  ZikaV  infections  and  differential
iagnosis with  dengue  and  Chikungunya  fever
he  dengue  and  Chikungunya  viruses  have  similar  clinical
igns  and  symptoms,  especially  in  the  early  stages  of  the
isease.51 This  also  occurs  with  ZikaV.  For  this  reason  it  is
ssential  to  differentiate  between  these  three  diseases.
ika
pproximately  80%  of  infected  individuals  are
symptomatic.52,53 When  present,  symptoms  can  last
rom  a  few  days  to  one  week.  Symptoms  are  usually  mild,
ith  characteristic  sudden  onset  of  fever,  arthralgia,
aculopapular  rash,  or  nonpurulent  conjunctivitis.  Accord-
ng  to  data  from  previous  outbreaks,  severe  forms  are  rare
nd  that  is  the  reason  why  hospitalizations  and  deaths  are
nusual.53,54 According  to  the  CDC,  the  diagnosis  of  Zika
hould  be  suspected  when  two  or  more  symptoms  (including
ever,  rash,  arthralgia,  or  conjunctivitis)  are  present  during
r  within  a  period  of  up  to  two  weeks  after  staying  in  an
ndemic  area  for  the  virus.55During  the  2007  Zika  outbreak  in  Micronesia,  the
ost  frequent  symptoms  were  skin  rash,  fever,  arthralgia,
nd  conjunctivitis;  headache,  myalgia,  retro-orbital  pain,
dema,  and  vomiting  were  less  common.  Of  the  49  conﬁrmed
l
r
i
fNunes  ML  et  al.
ases,  no  hospitalizations,  hemorrhagic  manifestations,  or
eaths  were  reported.53
engue  fever
engue  should  be  suspected  in  all  patients  residing  in
ndemic  areas  or  who  traveled  to  these  regions  in  the  past
wo  weeks.56 The  diagnosis  should  be  considered  in  patients
ith  fever  (sudden  onset,  with  a  peak  of  39--40 ◦C),  dif-
use  skin  ﬂushing,  leukopenia,  and  thrombocytopenia.57,58
he  symptoms  last  for  approximately  ﬁve  to  seven  days.
eadache,  arthralgia,  back  pain,  myalgia,  bone  pain,  and
astrointestinal  symptoms  (anorexia,  vomiting,  and  discom-
ort)  are  common.  Retro-orbital  pain,  after  light  pressure
s  applied  to  the  eyeball,  is  also  usual.56,57 Signs  sugges-
ive  of  hemorrhage  include  petechiae,  purpura,  epistaxis,
ingival  and  vaginal  bleeding,  melena,  and  hematemesis.  In
his  situation,  physicians  must  be  alert  for  dengue  hemor-
hagic  fever,  which  can  result  in  circulatory  collapse  and,
onsequently,  shock.56,57
hikungunya
nlike  dengue  and  Zika,  most  people  infected  with  the
hikungunya  virus  are  symptomatic,  with  less  than  15%
eing  asymptomatic.59,60 The  time  of  viremia  is  usually  one
eek.61 The  fever  has  a  rapid  onset,  with  high  tempera-
ures  (generally  >39 ◦C),  accompanied  by  myalgia,  asthenia,
eadache,  arthralgia,  and  rash.  Soon  after  the  onset  of
ever,  there  are  complaints  of  severe  myalgia  and  arthralgia,
hich  will  even  prevent  patient  ambulation.62 Rash  occurs
n  20--80%  of  cases  with  maculopapular  presentation  and
sually  located  on  the  trunk.63 Less  common  and  unspeciﬁc
ymptoms  include  pruritus,  lymphadenopathy,  and  digestive
isorders.63 Patients  requiring  hospitalization  are  usually
lderly  and  those  with  coexisting  disorders  (cardiac,  respira-
ory,  neurological,  or  diabetes).  Another  group  with  a  high
isk  for  severe  infection  is  the  neonatal  group  (especially
others  who  carried  the  virus  during  pregnancy  and  expo-
ure  during  birth)  and  young  children.64
aboratory  diagnosis
aboratory  diagnosis  of  ZikaV  infections  is  mainly  based
n  molecular  biology  and  serologic  tests.65,66 Ampliﬁcation
f  the  viral  RNA  through  reverse  transcription-polymerase
hain  reaction  (RT-PCR)  can  be  performed  in  several  biolog-
cal  materials  such  as  serum,  cerebrospinal  ﬂuid,  amniotic
uid,  saliva,  and  urine.9,10,67 In  patients  with  suspected
nfection  by  horizontal  transmission,  its  positivity  is  asso-
iated  with  the  acute  phase  of  infection  between  three
nd  seven  days  after  the  onset  of  symptoms,  when  low-
evel  viremia  usually  occurs.3,65 When  available,  they  are  the
iagnostic  tests  of  choice  after  the  acute  phase.  The  inter-
retation  of  serological  tests  for  ZikaV,  such  as  ELISA  IgM
nd  IgG  or  plaque-reduction  neutralization  test  (PRNT)  must
e  performed  carefully,  as  they  show  cross-reactivity  with
ther  arboviruses,  especially  in  patients  previously  infected
ith  other  ﬂaviviruses,  such  as  dengue  fever.65 Ideally,  sero-ogy  for  dengue  should  be  performed  concomitantly  and
epeated  after  two  weeks  for  comparison  of  titers;  positivity
n  neutralizing  antibody  titers  four  times  higher  than  dengue
ever  is  considered  conﬁrmatory.53,67
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In  suspected  cases,  as  there  is  no  complete  knowledge
of  the  accuracy  of  several  tests  in  the  diagnosis  of  con-
genital  infection,  RT-PCR  should  be  performed  if  available,
ideally  within  the  ﬁrst  two  days  in  cord  blood,  cerebrospinal
ﬂuid,  and  placenta,  associated  to  antibody  measurements
in  cerebrospinal  ﬂuid  and  serum.  The  immunohistochemical
test  for  ZikaV  in  the  placenta  and  umbilical  cord  should  also
be  performed  whenever  possible.  The  detection  of  ZikaV
in  any  of  the  abovementioned  materials  through  RT-PCR  or
immunohistochemistry  establishes  a  diagnosis  of  congeni-
tal  infection.  The  reagent  serology  is  conﬁrmatory  when
titers  are  higher  than  in  dengue  serology,  as  described
above.  In  the  event  of  fetal  death,  the  diagnosis  consists
of  performing  RT-PCR  and  immunohistochemistry  in  fetal
tissue.67
Neuroimaging  and  ZikaV
According  to  the  guidelines  of  the  American  Academy  of
Neurology  on  Microcephaly,  neuroimaging  studies  are  useful
in  identifying  structural  lesions  in  the  assessment  of  children
with  microcephaly,  helping  in  the  investigation  of  genetic,
acquired,  or  environmental  etiologies;  magnetic  resonance
imaging  (MRI)  is  the  most  accurate  method  for  the  identiﬁ-
cation  of  speciﬁc  patterns  that  can  help  diagnosis.22
Regarding  congenital  infections,  the  mechanism  of  infec-
tion  and  brain  damage  depends  on  the  etiological  agent,
determining  neuroradiological  and  pathological  manifesta-
tions  with  distinct  patterns.  Viral  agents,  for  instance,
tend  to  produce  a  selective  necrosis  of  speciﬁc  cell  types,
whereas  bacteria  and  fungi  are  less  selective.  Moreover,
different  patterns  of  calciﬁcations  seen  at  the  imaging
and  pathological  studies  are  typical  of  STORCH  infections
(syphilis,  toxoplasmosis,  rubella,  CMV,  HIV,  and  herpes  sim-
plex),  and  the  time  of  the  insult  during  fetal  life  is  related
to  the  teratogenic  or  encephaloclastic  effects.68
The  main  objective  of  the  imaging  assessment  of  a  pos-
sible  intrauterine  infection  by  ZikaV  is  the  detection  of
neurological  complications  related  to  transplacental  infec-
tion,  such  as  microcephaly,  cerebral  calciﬁcations,  neuronal
migration  disorders,  loss  of  brain  tissue,  and  ventricular
system  dilation.  The  extent  and  severity  of  intracranial
alterations  are  directly  related  to  the  gestational  period
when  the  fetus  was  infected  by  the  virus;  it  is  more  severe
and  extensive  during  the  ﬁrst  trimester  of  pregnancy  and
milder  in  the  third  trimester.  The  imaging  assessment  of  the
fetus  or  newborn  has  been  indicated  in  cases  of  maternal
ZikaV  infection,  either  conﬁrmed  or  inconclusive,  as  well  as
through  laboratory  tests  or  compatible  clinical  pictures.
During  the  prenatal  period,  obstetric  ultrasonography  is
the  exam  of  choice  and  is  recommended  for  the  investigation
of  possible  structural  abnormalities  of  the  central  nervous
system  and  for  monitoring  fetal  and  brain  growth  every  three
to  four  weeks.69
In  the  postnatal  period,  transfontanellar  ultrasonography
is  the  initial  method  of  investigation  for  the  newborn  with
a  head  circumference  ≤32  cm.  The  presence  of  any  abnor-
malities  detected  by  the  transfontanellar  ultrasound  should
be  investigated  through  more  detailed  examinations  with
higher  diagnostic  accuracy,  such  as  computed  tomography
or  magnetic  resonance  imaging.67
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The  brain  abnormalities  resulting  from  intrauterine  infec-
ion  by  ZikaV  have  been  described  mainly  by  computed
omography  in  the  postnatal  period.  The  main  imaging  ﬁnd-
ngs  originate  from  a  series  of  35  cases  of  microcephaly,  born
o  mothers  who  had  contact  with  endemic  areas.  Of  the  total
f  35  infants,  27  were  submitted  to  computed  tomography
nd  subsequently  reported  to  the  CDC.5 The  imaging  ﬁndings
n  that  cohort  consisted  of  cerebral  calciﬁcations,  predomi-
antly  periventricular,  but  also  of  calciﬁcations  in  the  brain
arenchyma,  thalamus,  and  basal  ganglia.  Neuronal  migra-
ion  anomalies  were  also  detected,  such  as  lissencephaly,
achygyria,  and  polymicrogyria,  present  in  up  to  one-third
f  cases.  Ventriculomegaly  secondary  to  cortical/subcortical
trophy  has  also  been  often  found.5 There  are  also  case
eports  that  used  other  imaging  methods,  such  as  obstet-
ic  ultrasound  to  carry  out  intrauterine  investigation  of
regnant  women  with  a  history  of  ZikaV  infection,  which
howed  gross  cerebral  calciﬁcations,  abnormalities  in  the
erebellar  vermis  and  corpus  callosum  dysgenesis.70
Recently,  the  case  report  of  a  fetus  with  conﬁrmed
ikaV  infection  submitted  to  autopsy  and  neuropathologi-
al  study  showed  microcephaly,  predominantly  cortical  and
ubcortical  calciﬁcations,  simpliﬁed  gyral  pattern,  neuronal
igration  disorders,  loss  of  brain  tissue,  and  asymmetric
entricular  dilation.  Although  that  study  did  not  include
ore  advanced  neuroimaging  studies,  the  described  sono-
raphic  ﬁndings  would  certainly  be  better  identiﬁed  and
emonstrated  by  fetal  or  postnatal  computed  tomography
r  magnetic  resonance  imaging.71
trategies  for  studying  the  association  between
ikaV and  microcephaly
lobal  understanding  of  normal  neurodevelopment  and  its
ossible  alterations  depends  on  extensive  knowledge  of  the
rain  formation  and  the  pattern  of  connections  between
eurons  and  between  brain  regions,  as  well  as  the  synaptic
ommunications  that  constitute  these  adequate  connec-
ions.  The  new  methods  of  cell  and  organoid  models  allow
or  in  vitro  simulations  of  the  processes  involved  in  embry-
nic  neurogenesis,  the  possible  alterations  or  interventions
hat  may  be  related  to  abnormal  brain  development.  It  is
ow  possible  to  elucidate  issues  regarding  the  main  gaps
n  knowledge  on  brain  formation,  generating  unique  results
n  embryonic  neurogenesis  and  all  the  processes  involved
uring  cortical  development,  as  well  as  the  complete  under-
tanding  about  the  action  of  agents  that  can  potentially
ause  alterations  in  embryonic  neurodevelopment.
Human  neurons  and/or  glial  cells  are  not  readily  available
or  experimental  research.  Studies  of  pathologies  associ-
ted  with  the  central  nervous  system  have  traditionally  been
imited  to  animal  models  or  less  relevant  cell  lines  for  the
nderstanding  of  neuronal  pathophysiology.72--74 The  impor-
ance  of  using  human  cells  similar  to  the  disease  to  be
nvestigated  is  evident  by  the  number  of  drugs  that  show
fﬁcacy  and  safety  when  tested  in  animal  models,  but  sub-
equently  fail  in  clinical  trials.74 Thus,  it is  necessary  to
se  new  models  that  accurately  represent  real  human  dis-
ases  and  their  physiological  peculiarities  to  improve  the
uccess  rate  of  new  discoveries,  mainly  those  related  to
eurodevelopment.73
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The  technology  required  to  generate  the  so-called
ell  models  is  currently  available,  capable  of  reproducing
omatic  cells  at  the  embryonic  level,  or  even  producing  mini-
rains  from  these  reprogrammed  cells.  These  models  have
igh  relevance  for  the  study  of  diseases  in  humans,  providing
xcellent  conditions  for  the  understanding  of  mechanisms
nd  constituting  an  accomplished  tool  for  high-yield  exper-
ments,  also  allowing  for  the  construction  of  platforms  for
he  screening  of  new  drugs  in  several  diseases.72
Cells  obtained  by  cell  reprogramming  are  called  induced
luripotent  stem  cells  (iPS)  and  are  very  similar  to  embryonic
tem  cells,  with  the  same  characteristics  of  self-renewal
nd  differentiation  potential  in  three  lines  of  embryonic
eaﬂets.75,76 The  use  of  the  iPS  cell  generation  technol-
gy  is  based  on  two  major  action  areas,  the  generation
f  speciﬁc  cells  for  use  in  regenerative  medicine,  and/or
odeling  of  disease  and  screening  for  new  drugs.  iPS  cells
an  be  generated  from  patients  with  a  particular  disease
r  from  healthy  individuals,  and  subsequently  differenti-
ted  into  adult  cells.  Based  on  diseases  whose  phenotype  is
xpressed  in  adult  cells,  genome  editing  and  correction  can
e  performed,  as  well  as  screening  for  compounds  capable
f  correcting  cell  disorder  and  evaluation  of  the  possible  tox-
city  of  some  drugs  in  these  cells.73 From  an  iPS  cell,  in  vitro
mall  organoids  with  a  miniature  organization  very  similar  to
hat  of  the  human  brain  can  be  obtained,  which  are  called
ini-brains,  being  able  to  recapitulate  a  surprising  number
f  brain  development  characteristics.
Viral  infections  capable  of  promoting  changes  in  neu-
odevelopment  can  be  investigated  through  the  exposure  of
uman  iPS  cells  to  viruses,  allowing  for  a  detailed  study  of
he  different  stages  of  viral  infection  progression  and  the
onsequences  of  exposure  during  embryonic  brain  devel-
pment.  D’Aiuto  et  al.,  in  2014,  reported  a  study  on  the
usceptibility  of  human  iPS  cells  to  cytomegalovirus  and
ts  performance  during  the  formation  of  an  adult  neu-
on.  The  study  showed  signiﬁcant  differences  in  alterations
aused  by  cytomegalovirus  to  embryonic  cells,  neural  pre-
ursor  cells  and  adult  neurons,  suggesting  that  exposure  to
ytomegalovirus  in  the  embryonic  period  is  crucial  to  the
evelopment  of  brain  malformations  caused  by  the  virus.77
In  cases  of  microcephaly  caused  by  genetic  muta-
ions,  for  instance,  mini-brains  were  generated  from  cells
iPS)  derived  from  skin  ﬁbroblasts  from  a  patient  with
icrocephaly.  The  generated  mini-brains  resembled  the
henotype  of  microcephaly,  being  much  smaller  when  com-
ared  with  mini-brains  generated  from  control  patient  cells,
llowing  for  a  detailed  study  of  embryonic  neurogenesis,
specially  the  cortical  formation  of  these  brains.78,79
iscussion
he  association  between  by  the  ZikaV  infection  during  preg-
ancy  and  the  development  of  microcephaly  has  alarmed
he  population  worldwide.5--8 Microcephaly  is  a  disorder  of
he  neuronal  proliferation  phase,  which  occurs  early  in  preg-
ancy  (third  to  fourth  month)12 and,  in  some  described
ases,  appears  to  coincide  with  the  symptoms  of  the  infec-
ion  in  the  mother.  As  the  criteria  for  the  deﬁnition  of
icrocephaly  have  not  been  used  in  a  standardized  manner
nd  as  there  was  clearly  an  underreporting  of  such  cases  in
A
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razil,  it  is  difﬁcult  to  establish  with  certainty  whether  there
s  a  real  increase  in  the  incidence  of  this  pathology.22--26
dditionally,  the  available  neuroimaging  studies  show  that
ther  malformations  of  fetal  cortical  development  are  also
resent,  such  as  neuronal  migration  disorders  (third  to  ﬁfth
onth  of  pregnancy)  and  diffuse  calciﬁcations  (neuronal
eath),  suggesting  either  a  long  term  of  the  virus  patho-
enesis  in  the  CNS,  or  the  susceptibility  of  more  phases  of
ortical  development.5,12--14,70
Considering  the  broad  dissemination  of  the  Aedes  aegypti
n  Brazil  and  that  the  methods  used  for  vector  population
ontrol  are  slow  to  show  results,  it  is  expected  that  cases
f  ZikaV  infection  will  continue  to  increase,  the  acquisition
f  more  knowledge  about  both  the  pathology  and  the  etio-
ogical  agent  an  urgent  priority.  Recent  studies  suggest  that
lterations  in  the  molecular  components  of  ZikaV,  especially
f  the  E  protein  present  on  the  virus  surface,  could  be  cor-
elated  with  an  increased  ‘‘aggressiveness’’  of  the  ZikaV,
einforcing  its  neurotropism  and  capacity  to  cause  disease  in
umans.40,42 The  situation  requires  multiple  and  multidisci-
linary  approaches  to  control  the  vector  and  ZikaV  infection,
ncluding  the  education  of  the  population.  A  well-informed
ediatrician  is  a  central  part  of  this  process.
It  is  a  fact  that  the  ZikaV  can  overcome  the  placental  bar-
ier  and  reach  the  amniotic  ﬂuid  and  fetal  tissues.11 But  it  is
ecessary  to  reassure  pregnant  women,  as  it  is  not  possible
o  afﬁrm  that  this  increase  in  microcephaly  notiﬁcations  is
olely  related  to  the  virus,  as  many  initially  suspected  cases
ere  ruled  out.23 Cases  with  laboratory  conﬁrmation  are  few
n  relation  to  the  high  number  of  notiﬁcations;  neverthe-
ess,  prevention  measures  are  still  necessary  and  should  be
dentiﬁed.
The  availability  of  tests  for  the  laboratory  diagnosis  of
ikaV  infection,  both  in  the  acute  phase  and  later,  is  still  very
estricted.  The  difﬁculty  in  conﬁrming  or  ruling  out  infec-
ion  also  affects  the  understanding  of  the  natural  course  of
he  disease  and  its  association  with  microcephaly  and  also
ith  Guillain--Barré  syndrome.54 Because  of  the  great  world-
ide  concern  regarding  the  teratogenic  potential  of  ZikaV
nfection,  there  will  be  greater  efforts  for  the  development
f  more  affordable  testing  with  greater  accuracy,  such  as
erology  with  less  risk  of  cross-reactivity.80
In  conclusion,  there  is  a clear  temporal  association
etween  the  increased  reporting  of  cases  of  microcephaly
nd  the  ZikaV  epidemic,  mainly  in  the  Northeast  of  Brazil.
owever,  the  development  of  diagnostic  techniques  to
onﬁrm  a  cause-and-effect  association,  the  pathogenesis
echanisms  of  ZikaV  infection  in  the  central  nervous  sys-
em,  and  more  adequately  deﬁned  diagnostic  criteria  for
he  identiﬁcation  of  cases  of  microcephaly  that  should  be
ubmitted  to  investigation  are  still  required.
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